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Abstract
Introduction: The recent availability of efficacious prevention interventions among stable couples offers new opportunities for
reducing HIV incidence in sub-Saharan Africa. Understanding the dynamics of HIV incidence among stable couples is critical to
inform HIV prevention strategy across sub-Saharan Africa.
Methods: We quantified the sources of HIV incidence arising among stable couples in sub-Saharan Africa using a cohort-type
mathematical model parameterized by nationally representative data. Uncertainty and sensitivity analyses were incorporated.
Results: HIV incidence arising among stable concordant HIV-negative couples contribute each year, on average, 29.4% of total
HIV incidence; of those, 22.5% (range: 11.1%39.8%) are infections acquired by one of the partners from sources external to the
couple, less than 1% are infections acquired by both partners from external sources within a year and 6.8% (range: 3.6%11.6%)
are transmissions to the uninfected partner in the couple in less than a year after the other partner acquired the infection from
an external source. The mean contribution of stable HIV sero-discordant couples to total HIV incidence is 30.4%, with most of
those, 29.7% (range: 9.1%47.9%), being due to HIV transmissions from the infected to the uninfected partner within the
couple. The remaining incidence, 40.2% (range: 23.7%64.6%), occurs among persons not in stable couples.
Conclusions: Close to two-thirds of total HIV incidence in sub-Saharan Africa occur among stable couples; however, only half of
this incidence is attributed to HIV transmissions from the infected to the uninfected partner in the couple. The remaining
incidence is acquired through extra-partner sex. Substantial reductions in HIV incidence can be achieved only through a
prevention approach that targets all modes of HIV exposure among stable couples and among individuals not in stable couples.
Keywords: stable couples; sources of infection; HIV incidence; Sub-Saharan Africa; demographic and health surveys;
mathematical model.
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Introduction
The majority of the adult population in sub-Saharan Africa
(SSA) live in marital or co-habiting couples [1]. A considerable
fraction of these stable couples (SCs) are HIV sero-discordant
(that is, one partner testing HIV sero-positive while the other
testing HIV sero-negative) [15]. Recent randomized clinical
trials have demonstrated the potential for averting much
of the HIV heterosexual transmission among stable HIV sero-
discordant couples (SDCs) using highly efficacious HIV preven-
tion interventions such as antiretroviral therapy (ART) [69].
This progress in HIV prevention research revealed new
horizons for HIV policy and programming in SSA and placed
SDCs on the list of priorities for HIV prevention efforts [1012].
Yet, reaching a consensus on an effective HIV prevention
strategy in SSA that factors SDCs entails a comprehensive
understanding of the sources of HIV incidence arising in the
population, particularly among SCs.
We recently quantified the contribution of HIV incidence
within SDCs to total HIV population-level incidence (SDCint)
across SSA [13]. We also estimated the fraction of HIV
infections arising among SDCs that are due to sources
external to the couple [14]. We further quantified the risk
of HIV transmission from the infected to the uninfected
partner in the SDC [15]. In this article, we complement
our work by extending our analysis to the sources of HIV
incidence across the different types of SCs for 24 countries
in SSA. Specifically, we assess the contribution of HIV
incidence among stable concordant HIV-negative couples
(SCNCs) relative to total HIV population-level incidence
where: a) one of the partners acquires the infection from a
source external to the couple (SCNCext1), b) each of
the partners acquires the infection from a source external
to the couple (SCNCext2) and c) one partner acquires
the infection from a source external to the couple and
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then transmits the infection to the uninfected partner in
the couple shortly after acquiring the infection (SCNCextint).
We also estimate the contribution of HIV incidence among
SDCs where the uninfected partner acquires the infec-
tion from a source external to the couple (SDCext). We
further provide an estimate for the incidence contribution
of individuals not in a SC where HIV infection is acquired
through sexual contacts outside of the context of marital or
cohabiting partnerships (NSC). Finally, we update the results
of our earlier work on SDCs [13,14] through the use of
recently available survey data, in addition to including
countries that were not covered earlier, and the use of
a more elaborate mathematical modeling framework for
generating these estimates.
Methods
We constructed a cohort-type mathematical model that esti-
mates the contribution of HIV incidence stratified by couple
status and source of infection to total HIV incidence in the
population over the course of a year. The model uses the
calculated risks of HIV transmission and acquisition among
SCs to derive the annual number of new HIV infections arising
among SCs and the relative contribution of each source of
incidence to the total HIV incidence in the population.
Model structure and measures’ definition
Our model sets out to ask the following question: if there is a
national screening survey at a point in time (at Time 0) that
identifies individuals engaged in SCs and others not engaged
in SCs, what proportion of these individuals would acquire
HIV over the following year (at Time 1), that is within a year
of observation, and how? Figure 1 shows the possible
changes to the HIV sero-status of the three types of SCs
that are identified in the baseline cross-sectional survey at
Time 0 (SCNCs, SDCs or concordant HIV-positive couples),
and changes to the HIV sero-status of individuals not in SCs,
Population in
reproductive age at Time 0 
Possible outcome
scenarios at 
Time 1 (One year later)
Acronym Description
Mathematical expression for
the number of new HIV
infections per year  
SC N C
Stable concordant HIV-negative couples where no HIV sero-
conversions occur between Time 0 and Time 1. Zero incidence
1extSC N C ×
Stable concordant HIV-negative couples where one of the partners
acquires the infection from a source external to the couple. 
2λ (1–λ) N
couples PSCNC
SCNC
SCNC
SDC
SDC
2λ2N
couples P
λN
couples P
N
rep_ age(1–fin _ couples) (1–P)j
2extSC N C ×
Stable concordant HIV-negative couples where each of the
partners acquires the infection from a source external to the
couple. 
ext in tSC N C +
Stable concordant HIV-negative couples where one partner
acquires the infection from a source external to the couple and
then transmits the infection to the uninfected partner in the couple.
These sero-conversions define the non-identifiable HIV incidence
among stable discordant couples as these couples are not
identified as discordant couples in the cross-sectional surveys.
They are identified as concordant negative at Time 0 and as
concordant positive at Time 1.    
2t6mthsλNcouples P
SD C
Stable HIV discordant couples where no HIV sero-conversions 
occur between Time 0 and Time 1. Zero incidence
in tS D C
Stable HIV discordant couples where the infected partner in the
couple transmits the infection to the uninfected partner in the
couple. These infections define the identifiable HIV incidence
among stable discordant couples as these HIV transmissions
occurred in couples that have already been identified as discordant
at Time 0.  
t1yearNcouplesP
extSD C
Stable HIV discordant couples where the uninfected partner
acquires the infection from a source external to the couple. 
Stable concordant HIV-
negative couples (SCNC) 
Stable HIV discordant
couples (SDC) 
SC P C
Stable concordant HIV-positive couples where no further HIV
sero-conversions are possible between Time 0 and Time 1. Zero incidence
N SC
Individuals not in a stable couple acquiring HIV infection through
sexual contacts outside the context of marital or cohabiting
partnerships. 
Stable concordant HIV-
posive couples (SCPC) 
Individuals not in a
stable couple (NSC) 
Figure 1. Model conceptualization for HIV incidence in the population classified based on the sero-status of stable couples and source of
infection. The table shows the possible outcome scenarios and the associated mathematical expressions for the different HIV incidence
measures. The green circle indicates an HIV sero-negative individual, while the red circle indicates an HIV sero-positive individual.
*Parameters include l: the probability of an HIV sero-negative partner in a stable couple (SC) to acquire the infection from a source external
to the couple over the course of one year; Ncouples: the number of SCs identified in the baseline screening cross-sectional survey at Time 0;
PSCNC: the prevalence of stable concordant HIV-negative couples among all couples; PSDC: the prevalence of stable HIV discordant couples
among all couples; t6mths: the probability that the index partner who acquired the infection from an external source will transmit the infection to
the uninfected partner during the six months following the acquisition of HIV; t1year: the probability that the index partner in a stable HIV
discordant couple will transmit the infection to the uninfected partner during the time between the two cross-sectional surveys at Time 0 and
Time 1; Nrep_age: the size of the population in reproductive age; fin_couples: the fraction of the population in reproductive age engaged in SCs;
P: HIV prevalence in the population; 8: the HIV population-level incidence rate.
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one year later at Time 1. The mathematical expressions used
to assess the annual number of new HIV infections arising
among these population sub-groups are also summarized in
this figure and discussed further in the Supplementary file.
In summary, we drew a map of HIV incidence stratified
by couple status and source of infection by measuring, for
each country, the contribution of six different types of HIV
incidence to total HIV incidence arising in the population
over the course of a given year of observation (Figure 1).
The latter is defined as the number of new HIV infections
arising within a year among susceptible individuals in reproduc-
tive age. This measure defines the denominator in all six
contribution measures, and is calculated using HIV population-
level incidence rate and the estimated number of uninfected
individuals in reproductive age for each country (Table 1 and
Supplementary file).
Contributions among SCNCs:
1) SCNCext1 is the contribution of new HIV infections
arising among SCNCs where only one of the partners
acquires the infection from a source external to the
couple, relative to total HIV incidence in the population.
The number of infections here is calculated using the
probability of acquiring the infection from a source
external to the couple by one of the partners and the
number of SCNCs in the population (Figure 1 and
Supplementary file).
2) SCNCext2 is the contribution of new HIV infections
arising among SCNCs where both partners acquire the
infection from a source external to the couple within
the same year, relative to total HIV incidence in the
population in that year. The number of infections here is
calculated using the probability of acquiring the infec-
tion from a source external to the couple by both
partners and the number of SCNCs in the population
(Figure 1 and Supplementary file).
3) SCNCextint is the contribution of new HIV infections
arising among SCNCs where the index partner acquires
the infection from a source external to the couple,
on average half the way through the year of observa-
tion, and transmits HIV to the other partner during the
following half of the year, relative to total HIV incidence
in the population. The number of infections here is
calculated using the probability of acquiring the infec-
tion from a source external to the couple by one of the
partners, the likelihood of transmitting the infection to
the uninfected partner within six months following HIV
acquisition and the number of SCNCs in the population
(Figure 1 and Supplementary file).
Contributions among SDCs:
1) SDCint is the contribution of new HIV infections arising
among SDCs where the HIV infected partner transmits
the infection to the uninfected partner, relative to
total HIV incidence in the population. The number of
infections here is calculated using HIV transmission
probability per partnership over the course of a year of
observation and the number of SDCs in the population
(Figure 1 and Supplementary file).
2) SDCext is the contribution of new HIV infections arising
among SDCs where the uninfected partner acquires
HIV from a source external to the couple, relative to
total HIV incidence in the population. The number
of infections here is calculated using the probability
of acquiring the infection from a source external to the
couple and the number of SDCs in the population
(Figure 1 and Supplementary file).
Contribution among individuals not in SCs:
1) NSC is the contribution of new HIV infections arising
among susceptible individuals in reproductive age who
are not part of a SC, relative to total HIV incidence
in the population. The number of infections here is
calculated using HIV population-level incidence rate and
the number of susceptible individuals who are in
reproductive age but not part of a SC (Figure 1 and
Supplementary file).
Model parameterization
Multiple data sources were used to obtain the model
parameters with the primary source being the Demographic
and Health Surveys (DHS), which are standardized nationally
representative household-based surveys [16]. We analyzed
the most recent DHS data for 24 countries in SSA where an
HIV serological biomarker survey has been conducted [16].
These data were complemented by population size informa-
tion from the United Nations World Population Prospects
Database [17] to calculate country-specific demographic,
behavioural and epidemiological indicators (Table 1).
As per DHS, a SC is defined as a man and a woman living
in a consensual union within a household at the time of
the DHS cross-sectional survey [18]. Accordingly, polygamous
arrangements may contribute multiple SCs. SCs where one or
both partners did not test for HIV were excluded from
our analysis. Missing HIV information among all SCs ranged
from 0.5% to 27.3% (mean of 10.8%) across countries. DHS
guidelines were followed in applying to our calculations the
sampling weights retrieved from the DHS datasets [18,19].
Further details related to the management of DHS datasets
can be found in the Supplementary file.
Following the methodology applied in our earlier work
[13], we calculated the total HIV incidence in the population
using HIV population-level incidence rates estimated using
the Joint United Nations Programme on HIV/AIDS (UNAIDS)
SPECTRUM model [20]. When these were not available,
HIV population-level incidence rates were derived from the
DHS HIV prevalence measures using the expression HIV
population-level incidence rate ¼ HIV population prevalence
Duration of infection
[21]. Further
details can be found in the Supplementary file.
To estimate HIV incidence arising among susceptible
individuals that are not in SCs, we assumed that the risk of
HIV acquisition among these individuals is equal to the aver-
age HIV population-level incidence rate among all susceptible
individuals in the population (Figure 1 and Supplementary
file) [14]. Country-specific values of the HIV population-level
incidence rates can be found in Table 1.
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Table 1. Key demographic and HIV-related indicators across the 24 sub-Saharan African countries included in our analysis
Country Year
Pop in rep
age
Fraction of
pop in rep
age that is
in stable
couples (%)
Number of
stable
couples
HIV
pop
prev
(%)
Couples
tested
Prev of
stable
discordant
couples
(%)
Prev of
stable
concordant
positive
couples (%)
Prev of
stable
concordant
negative
couples (%)
Fraction of
HIV
infected
females in
SDCs (%)
Fraction of
circumcised
males in SDCs
with HIV infected
females (%)
MC in
the
pop
(%)
Condom
use at last
sex among
couples
(%)
HIV pop
inc
HIV
pop
inc
rate¥ l¢
Senegal 2011 11,248,786 54.2 3,045,609 0.5 1586 0.9 0.4 98.8 35.8 100* 98.3* 2.0 8954 0.08 0.03
Niger 2006 4,714,950 76.3 1,798,871 0.7 2035 1.0 0.2 98.9 38.9 91.1 99.4 0.2 4683 0.10 0.04
Burkina Faso 2010 14,978,556 71.5 5,355,583 1.0 4894 1.2 0.2 98.6 56.8 90.9 88.4 3.6 10,378 0.07 0.02
Mali 2006 5,097,581 74.9 1,909,554 1.2 2467 1.2 0.4 98.5 72.1 94.2 97.7 0.7 7051 0.14 0.07
Congo 2007 29,807,400 61.4 9,147,146 1.3 2145 1.6 0.2 98.2 64.8 100 97.5 1.9 35,315 0.12 0.05
Burundi 2010 7,783,616 58.6 2,282,156 1.4 1933 1.1 1.1 97.8 59.8 40.2 30.9 1.6 9974 0.13 0.06
Ethiopia 2011 73,908,450 59.8 22,100,474 1.4 6183 1.1 0.6 98.4 60.4 93.0 92.4 0.5 94,707 0.13 0.07
Sierra Leone 2008 1,908,630 69.1 659,670 1.5 1576 1.7 0.5 97.8 58.8 100 97.9 1.0 2821 0.15 0.06
Liberia 2007 1,519,713 60.4 459,143 1.5 2255 1.9 0.3 97.9 61.6 100 98.7 2.5 2036 0.14 0.05
Guinea 2005 3,822,104 69.2 1,321,492 1.6 1851 1.6 0.4 98.1 41.0 93.6 99.0 0.8 5370 0.14 0.06
Ghana 2003 8,523,900 57.8 2,464,046 2.0 1811 2.7 1.0 96.3 45.6 100 95.2 3.4 16,700 0.20 0.07
Rwanda 2010 9,864,384 51.2 2,525,282 3.1 2808 2.2 2.4 95.4 40.6 28.5 13.3 5.1 16,251 0.17 0.04
Congo-
Brazzaville
2009 335,136 55.4 92,749 3.3 2427 4.7 1.0 94.3 59.5 99.2 99.2 9.4 1006 0.31 0.11
Cameroon 2011 17,766,494 56.9 5,052,791 4.3 2845 5.9 1.5 92.6 52.9 96.0 94.1 6.7 61,241 0.36 0.11
Cote d’Ivoire 2005 9,218,355 51.7 2,383,175 4.7 1266 5.6 1.3 93.1 62.7 100 96.6 4.6 37,612 0.43 0.17
Uganda 2011 31,770,463 61.3 9,742,412 5.2 4774 6.3 3.4 90.3 48.1 37.6 26.7 3.9 252,995 0.84 0.40
Tanzania 2007 15,983,193 58.6 4,678,680 5.7 2810 6.4 2.4 91.2 45.7 55.0 67.1 4.9 88,897 0.59 0.22
Kenya 2008 17,986,100 54.9 4,933,587 6.4 1228 6.0 3.1 91.0 54.1 79.2 86.0 3.4 90,948 0.54 0.22
Malawi 2010 5,505,484 63.1 1,737,393 10.7 3340 8.4 6.2 85.4 45.0 35.0 21.6 5.5 27,049 0.55 0.10
Mozambique 2009 19,920,615 69.6 6,935,362 11.5 2494 9.7 4.5 85.8 50.7 37.7 51.8 3.2 211,557 1.20 0.51
Zambia 2007 4,276,800 58.9 1,254,813 14.2 2300 11.0 7.8 81.1 40.3 10.6 12.9 6.6 42,561 1.16 0.38
Zimbabwe 2011 11,213,332 57.3 3,209,816 15.3 2368 11.2 10.2 78.6 40.1 15.0 9.2 8.3 99,702 1.05 0.30
Swaziland 2006 525,600 35.3 92,847 18.9 659 16.4 28.8 54.8 53.0 17.8 8.2 23.9 14,068 3.30 2.47
Lesotho 2009 962,189 47.9 230,420 23.0 805 17.2 18.7 64.0 44.4 62.3 52.0 24.1 19,789 2.67 1.55
Countries are shown in order of increasing HIV prevalence in the population.
Pop: population; Rep: reproductive; Prev: prevalence; SDC: stable HIV discordant couples; MC: male circumcision; Inc: incidence that is the number of new HIV infections per year.
*Data on male circumcision were not collected during the 20102011 round of the DHS for Senegal. The rates used are drawn from a previous Senegal DHS survey conducted in 2005; ¥HIV population-level
incidence rate estimated by SPECTRUM or derived using DHS HIV prevalence per 100 person-years; l¢: mean probability of acquiring HIV from sources external to the couple per 100 person-years derived
by performing 10,000 runs of model fits.
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The risk of HIV transmission within SDCs was calculated
using the best available empirical evidence for HIV transmis-
sion probability per heterosexual coital act (p) as measured
in the Rakai Study [22] and in the Partners in Prevention
HSV/HIV Transmission Study (Partners in Prevention Study)
(Table 2) [23,24]. To adjust for male circumcision (MC) and
self-reported condom use at last sex among SCs, we varied
the efficiency of HIV transmission among SDCs reporting
one or both interventions by applying to p multiplicative
factors adjusting for the efficacy of MC and condom use in
preventing HIV transmission. The effect of MC was stratified
based on whether the index partner in the couple is a male
or a female. We incorporated the coverage of condom use
through a fraction of the acts that are protected by the
partial efficacy of this intervention. The mathematical expres-
sions and further details on the calculation of the risk of HIV
Table 2. Model assumptions in terms of key parameter values related to HIV transmission and acquisition in sub-Saharan Africa
Assumptions Parameter values Source
Probability of acquiring HIV from sources external to the
couple per 100 person-years (l)
Derived from model fits Derived
Probability of acquiring HIV by an individual not in a stable
couple per 100 person-years (8)
HIV-population-level incidence rate estimated by
SPECTRUM or derived using DHS HIV prevalence
[16,20]
HIV transmission probability per coital act (p)
Acute infection (pacute) 0.036 [22,25]
Latent infection (platent) 0.0008 [22]
Average (p) using the Rakai and the Partners in
Prevention Studies
0.00115 Derived
Average (p) using the Rakai Study 0.0012 [22]
Average (p) using the Partners in Prevention Study 0.0011 [23,24,26]
Frequency of coital acts per month (n) 8.3 acts per month [22]
Demographic and epidemiological measures
Number of individuals in reproductive age in the
population (Nrep_age)
Table 1 [16]
Number of stable sexual couples identified in baseline
screening survey (Ncouples)
Table 1 [16]
Fraction of the population in reproductive age that are
engaged in stable couples (fin_couples)
Table 1 [16]
HIV prevalence in the population (P) Table 1 [16]
Prevalence of stable concordant HIV-negative couples
(PSCNC)
Table 1 [16]
Prevalence of stable HIV discordant couples (PSDC) Table 1 [16]
Fraction of females (index partners) among those initially
concordant HIV-negative couples (findexSCNC)
50% Assumption based on
Eyawo et al. [27]
Fraction of females (index partners) among
HIV discordant couples (findexSDC)
Table 1 [16]
Fraction of circumcised males among concordant HIV-
negative couples (fmcpop)
Equal to fraction of circumcised males in the
population (Table 1)
[16]
Fraction of circumcised males among HIV discordant
couples where the female is HIV infected (fmcindex)
Table 1 [16]
Fraction of coital acts protected by condom use (fcondom) Table 1 [16]
Efficacy of condoms in preventing HIV transmission per
condom-protected coital act (Econdom)
80% [24,28]
Efficacy of male circumcision in preventing HIV acquisition
among males per coital act (Emc)
58% [2932]
Duration
Between each round of the cross-sectional survey
(tfollow-up)
1 year Convention for this
model
Acute infection (tacute) 49 days [25]
Latent infection spent by index partner between two
subsequent cross-sectional surveys (tlatent)
134 days Derived
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transmission in presence of these interventions can be found
in the Supplementary file.
The likelihood of an HIV sero-negative partner in a SC
acquiring the infection from a source external to the SC
(defined here as l) was determined by the condition that
the total HIV incidence in the population, as estimated
from pooling together all incidence measures among SCs and
individuals not in SCs, must be equal to the total HIV
incidence as estimated independently using the SPECTRUM
model or derived using the DHS HIV prevalence (Table 1).
All incidence measures were then recalculated using this
fitted value of l, and estimates for the contributions of new
HIV infections among SCs to total HIV incidence in the
population were derived (Figure 1 and Supplementary file).
Uncertainty and sensitivity analyses
For each country, uncertainty analyses were performed for the
estimates of the contribution of each type of HIV incidence
by implementing 10,000 runs of the model using Monte
Carlo sampling from triangular probability distributions for
the ranges of demographic, biological and epidemiological
parameters (Table S1 in the Supplementary file). Parameter
ranges were primarily determined by the 95% confidence
intervals (CIs) around the country-specific DHS measures.
In the event where CIs were not available to provide a range,
plausibility ranges informed by the range of available data
in the literature or general consensus in the field were used
as parameter ranges. In each run, model fits were conducted
and an estimate for the probability of acquiring HIV from
sources external to the couple (l) was derived. Country-
specific distributions for the estimated contributions of
SCs to total HIV incidence by couple status and source of
infection were then generated and used to calculate the
mean and associated 95% CIs of these estimates (Figures 3
and 4).
Sensitivity analyses were conducted, using Kenya as an
example, to assess the sensitivity of the calculated contribu-
tion measures to variations in level of condom use at last sex
among SCs, MC coverage in the population and the fraction
of the population in reproductive age that are engaged in SCs
(Figure S2 in the Supplementary file).
Results
The key demographic and HIV-related indicators for the
24 countries in SSA can be found in Table 1. The estimated
numbers of new HIV infections per year among adults for
each country are also included in Table 1. Figures 2, 3 and 4
show the contributions of the six measures of HIV incidence
stratified by couple status and source of infection. Over the
course of a year of observation, stable concordant HIV-
negative couples (that is SCNCs) contribute on average 29.4%
of the total HIV population-level incidence across these
countries in SSA (Figures 2 and 3). Most new HIV infections
among these couples are due to one partner acquiring the
infection from a source external to the couple (SCNCext1),
with an average of 22.5% (range: 11.1%39.8%) across all
Figure 2. The average contributions to the total number of new HIV incident infections in a year in the population stratified by couples’
sero-status and source of HIV infection for 24 countries in sub-Saharan Africa. The average for each mode of exposure represents an average
over the country-specific mean contribution measures (fraction of new HIV infections relative to total HIV incidence in the population in a
given year). For each country, the mean contribution of each source of exposure to total HIV incidence was calculated based on 10,000 runs
of the model using Monte Carlo sampling from triangular probability distributions for the specified ranges of model parameters.
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Figure 3. Mean and 95% confidence interval of the contributions of HIV incidence among stable concordant HIV-negative couples to total
HIV incidence in the population in 24 countries in sub-Saharan Africa. The figure shows the contribution of HIV incidence among stable
concordant HIV-negative couple where: (A) one partner acquires the infection from a source external to the couple, (B) each of the partners
acquire the infection from a source external to the couple and (C) one partner acquires the infection from a source external to the couple and
then transmits it to the uninfected partner in the couple. Estimates were calculated based on 10,000 runs of the model for each country using
Monte Carlo sampling from triangular probability distributions for the specified ranges of uncertainty of the model parameters. Countries are
shown in order of increasing HIV prevalence. The horizontal line in the different panels represents the average for the contribution measure
in question across all countries.
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Figure 4. Mean and 95% confidence interval of the contributions of: (A) identifiable HIV incidence among stable HIV discordant couples due
to HIV transmission from the infected to the uninfected partner in the couple, (B) HIV incidence among stable HIV discordant couples due to
acquiring the infection from a source external to the couple and (C) HIV incidence among individuals not in stable couples. These measures,
for 24 countries in sub-Saharan Africa, are relative to total HIV incidence in the population in each country. Estimates were calculated based
on 10,000 runs of the model for each country using Monte Carlo sampling from triangular probability distributions for the specified ranges of
uncertainty of the model parameters. Countries are shown in order of increasing HIV prevalence. The horizontal line in the different panels
represents the average for the contribution measure in question across all countries.
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Figure 5. Correlation with HIV prevalence of the mean contribution of: (A) stable concordant HIV-negative couples where one partner
acquires the infection from a source external to the couple (SCNCext1), (B) stable concordant HIV-negative couples where each of the
partners acquire the infection from a source external to the couple (SCNCext2), (C) stable concordant HIV-negative couples where one
partner acquires the infection from a source external to the couple and then transmits it to the uninfected partner in the couple
(SCNCextint), (D) identifiable HIV incidence among stable HIV discordant couples due to HIV transmission from the infected to the uninfected
partner in the couple (SDCint), (E) HIV incidence among stable HIV discordant couples due to acquiring the infection from a source external to
the couple (SDCext) and (F) HIV incidence among individuals not in a stable couple (NSC). Values for the Pearson correlation coefficients (r)
and their associated p-values are incorporated. The analysis discounts the uncertainty in these measures (arising from uncertainty analyses).
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countries (Figure 3A). The average contribution of both
partners acquiring the infection from an external source
(SCNCext2), within the same year, is less than 1% (range:
0.004%0.4%) across the countries (Figure 3B). The contribu-
tion attributed to the index partner transmitting the infection
to the uninfected partner shortly after HIV acquisition from
an external source (SCNCextint), that is within the same year
of observation, is on average 6.8% (range: 3.6%11.6%)
across countries (Figure 3C).
New HIV infections occurring among SDCs identified as
sero-discordant at the onset of the year of observation
contribute on average 30.4% of the annual total HIV
population-level incidence across the countries (Figure 2).
Most of these HIV sero-conversions are due to acquiring the
infection from the HIV sero-positive partner in the couple
(SDCint; Figure 4A) with an average contribution of 29.7%
(range: 9.1%47.9%). HIV acquisitions from sources external
to the couple among SDCs (SDCext) contribute minimally
to total HIV incidence with an average of 0.7% (range:
0.1%3.1%) across these countries (Figure 4B). A substantial
proportion of HIV incidence occurs among individuals not
in SCs (NSC), with a mean of 40.2% (range: 23.7%64.6%)
across countries (Figures 2 and 4C).
Our findings suggest a strong dependence on HIV pre-
valence for SCNCext2 (Pearson correlation coefficient (r):
0.81, pB0.001, Figure 5B) and SDCext (r: 0.93, pB0.001,
Figure 5E), where higher contributions are observed in high
HIV prevalence countries. NSC is moderately correlated with
HIV prevalence (r: 0.53, p-value: 0.008, Figure 5F). Mean-
while, there is no evident correlation with HIV prevalence
for SCNCext1 (r:0.35, p-value: 0.093, Figure 5A),
SCNCextint (r:0.23, p-value: 0.283, Figure 5C) and SDCint
(r:0.33, p-value: 0.115, Figure 5D). The 95% CIs around
our estimates for the contributions, generated using the
uncertainty analyses, confirmed our finding of roughly equal
contribution of SCNCs, SDCs and individuals not in SCs to
total HIV incidence in the population across SSA (Figures 3
and 4).
Discussion
In this article, we complement our earlier work [1315]
by conducting a comprehensive quantitative mapping of
the contributions of all sources of HIV exposure to total HIV
incidence in the population stratified by couple status.
For completeness, we also include updates to few measures
reported earlier [13,14] by analyzing more recent, or first-
time available, DHS data for a number of countries and
further improving on the precision of some estimates using a
more complex mathematical model. Our findings show that
close to two-thirds of total HIV incidence every year in SSA
occur within the context of marriage or cohabitation, but
only half of these infections are actually attributed to HIV
transmissions from the infected to the uninfected partner
within a couple. The rest of the infections are acquired
through extra-partner sexual encounters to the couple. HIV
incidence in SSA appears to be roughly equally distributed
among concordant HIV-negative couples, HIV sero-discordant
couples and individuals not in SCs, with no dominant mode
of exposure through which individuals acquire HIV (Figure 2).
Among concordant HIV-negative couples, most HIV inci-
dence is due to one of the partners in the couple acquiring
HIV from an external source, while the incidence arising from
external HIV acquisitions by both partners within the same
year is minimal. HIV transmission to the uninfected partner
shortly after the external acquisition of HIV by the other
partner in the SCNC, is rather limited at less than 10% of HIV
incidence. Meanwhile, HIV sero-conversions among SDCs
due to the transmission of the infection from the HIV sero-
positive to the HIV sero-negative partner in the couple
contribute the majority of HIV incidence among SDCs.
These findings are in close agreement with those mea-
sured in the Rakai Study cohort where the contributions of
SCNCs, SDCs and individuals not in SCs were 38.5%, 24.0%
and 37.6%, respectively (after excluding partnerships with
incomplete HIV sero-status information) [33]. Our findings
are also in agreement with a recent modeling study that has
assessed the incidence contributions among SCs [34]. This
study used a mechanistic model that tracks HIV incidence
in the population in 18 countries in SSA, as opposed to our
programming-oriented approach that is based on a func-
tional definition of incidence among couples in a framework
of repeated cross-sectional surveys (Figure 1). Though there
are technical differences in the classification of couples’
status and the modes of exposure between the approach
of Bellan et al. [34] and that of our study, the findings of both
studies converge on the conclusion that HIV incidence in the
population is distributed roughly in equal proportions among
external infections to couples, within couples and among
persons not in couples.
Our updated estimates for HIV incidence among SDCs
reaffirm our earlier published work where HIV transmissions
from the infected to the uninfected partner in an SDC
contributed about a third of new HIV infections arising in the
population [13], and the vast majority of HIV incidence
arising among SDCs [14]. Indeed, our updated findings for the
risk of acquiring the infection externally among SDCs confirm
our earlier results as upper-bound estimates for this risk [14].
While SCNCs, SDCs and individuals not in SCs appear
to contribute equally to total HIV incidence in the popula-
tion across SSA, heterogeneity can still be observed across
countries (Figure S1 in the Supplementary file). One determi-
nant of the observed differences is the variability in HIV
prevalence across Africa (Table 1). This is manifested in the
strong association of SCNCext2 (Figures 3B and 5B) and SDCext
(Figures 4B and 5E) with HIV population prevalence. Such
results are expected as both measures depend proportionally
on l, the likelihood of acquiring the infection from a source
external to the couple (mathematical expressions in Figure 1),
which is higher in high HIV prevalence countries compared
to low HIV prevalence countries. The dependence of l on
HIV population incidence rate (that is indirectly on HIV
population prevalence) also explains the absence of a correla-
tion with HIV prevalence for SCNCext1 (Figures 1, 3A and 5A)
and SCNCextint (Figures 1, 3C and 5C). Meanwhile, the
moderate correlation with HIV prevalence of the fraction of
the population that are engaged in SCs, which appears to
be lower in high HIV prevalence countries, is reflected as
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a moderate correlation between NSC and HIV prevalence
(Figures 1, 4C and 5F).
Other factors could also affect the variability of the con-
tribution measures across SSA. These include the level of
condom use and coverage of MC in addition to the rates of
engagement in SCs across countries (Supplementary file).
Condom use and MC within SDCs reduce HIV transmission
within SDCs, therefore leading to lower SDCint and implicitly
higher contributions from HIV infections acquired through
sources external to the couple to explain the total observed
HIV incidence (Figures S2A and S2B in the Supplementary
file). Conversely, higher levels of engagement in SCs are asso-
ciated with an increase in the contribution of HIV incidence
occurring among SCs (Figure S2C in the Supplementary file);
so are the increased prevalence of HIV discordancy and
HIV-negative concordancy (Figure 1). The impact of varia-
tions in these factors on contribution measures is magnified
whenever more than one factor is at play. For example, in
Swaziland and Lesotho, the world’s largest HIV epidemic
centres, the higher levels of reported condom use among
SCs (Table 1), the lower rates of engagement in SCs (Table 1)
and the low prevalence of discordancy among partnerships
affected by HIV [1] have yielded lower SDCint contribution
(Figure 4A), and lower than expected SCNCext1 (Figure 3A)
and SCNCextint (Figure 3C) contributions but higher NSC
contribution (Figure 4C). Despite the observed heterogeneity,
the overall picture appears to suggest an equal contribu-
tion of SCNCs, SDCs and individuals not in SCs to total HIV
incidence in the population.
One of the highlights of our study is quantifying the
contribution of SCNCextint. Although, in principle, these
infections can be considered as occurring among SDCs
instead of SCNCs, the individuals who are newly infected
from a source outside the couple are unlikely to be detected
within a year by typical counselling and testing programs.
We label this type of HIV incidence as non-identifiable
HIV incidence among SDCs to distinguish it from that
where the infected partner transmits HIV to the uninfected
partner among couples that have been already identified
as SDCs in a cross-sectional survey before HIV transmission
to the partner (that is SDCint). The latter is labelled as
identifiable HIV incidence among SDCs and is discussed at
length in an earlier publication [13]. Our estimates assume
annual cross-sectional surveys, but these may not be feasible
to implement in resource-limited areas. A lower frequency
of cross-sectional surveys would increase the fraction of non-
identifiable HIV incidence among SDCs at the expense of the
fraction of identifiable HIV incidence among SDCs, making it
harder to implement effective SDCs-targeted interventions.
It is worth mentioning that our estimates for the con-
tribution measures factor in implicitly the role of polygamous
partnerships in driving HIV incidence among SCs. The DHS-
based samples of SCs include each union between a man and
a woman at the time of the cross-sectional survey irrespec-
tive of the number of concurrent unions.
Our results show that over one-third of HIV population-
level incidence occurs among individuals not in SCs (Figures 2
and 4C). This finding is probably not surprising since close to
half of HIV incidence in SSA occurs among youths [3537].
HIV infections arising among young individuals are probably
less likely to have been acquired in the context of spousal
partnerships and are more likely to have been acquired
by other modes of exposure such as through casual or
commercial sex encounters.
Although another third of new HIV infections in the popu-
lation arises from extra-marital partnerships, determining
the context in which these infections are acquired, whether
through contact with commercial sex networks, other forms
of high risk behaviour, or through casual sex, requires an
extended mathematical model that includes multiple risk
groups and heterogeneity in risk behaviour. Such an analysis
is beyond the scope of this publication whose purpose is to
quantify the contribution of the different sources of HIV
incidence occurring among SCs, rather than investigating the
actual drivers of the HIV epidemic across different settings.
The nature of our results where HIV incidence is dis-
tributed over different sources of exposure limits our ability
to develop specific HIV policy and programming recommen-
dations for SSA and suggests the need to simultaneously
address the different modes of HIV exposure in the popula-
tion. A treatment as prevention (TasP) approach [38], and the
new World Health Organization treatment recommendations
of increasing ART coverage to include HIV infected individuals
with CD4 countB500 [39], should achieve substantial
reductions in HIV transmission across all sources of exposure
to HIV infection. However, the specific impact of such inter-
ventions on HIV incidence through each source of exposure
is not yet known. ART coverage may vary from one sub-
population to another due to variable access to voluntary
counselling and testing services. Maintaining HIV infected
individuals in the treatment cascade may also vary across
sub-populations [40]. The impact of the interventions on the
onward transmission of HIV in the population is also not
yet entirely clear. With the increasing availability of data on
ART coverage, more complex mathematical models can be
designed to elucidate the impact of different HIV interven-
tions on HIV incidence through each of these modes of
exposure.
Our estimates are affected by the representativeness and
precision of available data. The recency of the epidemiolo-
gical and behavioural parameters used in our analyses was
determined by the availability of HIV biomarker information
in the DHS surveys. However, DHS surveys are increasingly
being implemented in SSA and only few surveys of those
used in our analysis were older than five years [16]. For some
countries, data were only available in small sample sizes
resulting in wide CIs around some of the measures. Our
estimates could also have been affected by inherent biases
in the DHS data such as the variability in response rate to HIV
testing [41], and selection bias in restricting our analysis to
couples with complete HIV sero-status information. Despite
these limitations, DHS surveys are the only standardized
nationally representative surveys conducted consistently
across the countries of SSA [16].
There are heterogeneities in risk behaviour and not all of the
population in reproductive age is necessarily sexually active.
Nevertheless, the measures that we used to parameterize
our model are averages for the specific sub-populations of
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interest regardless of the heterogeneities within. Heterogene-
ities can affect the estimates for a specific sub-group of a sub-
population of interest, but they may not affect the average
for the whole sub-population. This is especially true because
the focus of our study is on the short-term HIV incidence
within a year of observation where non-linear effects that are
sensitive to variability are not at play. Long-term projections,
however, including HIV onward transmission, could potentially
be affected by variability in risk behaviour.
Epidemic type or phase can affect the distribution of HIV
infection in a population, and potentially our results. None-
theless, our model uses empirical cross-sectional data of
HIV distribution and discordancy for a specific year, and
epidemic type and phase implicitly affects and drives these
data. Therefore effects due to epidemic type or phase should
be implicitly accounted for in our calculations.
We parameterized our model using the HIV transmission
probability per coital act (p) as measured in the Rakai Study
[22] and the Partners in Prevention Study [23,24] which,
to date, are the best available empirical evidence for this
measure. Yet, different biological or behavioural factors
may affect p across settings. We have already accounted in
our calculations for the coverage of MC and the uptake of
condom use among SCs in each country (Table 1). Still, other
factors may affect p but are difficult to adjust for due to data
limitations such as the presence of sexually transmitted
infections other than HIV [42,43], other co-infections that
increase HIV viral load [44,45], viral factors [4648], differ-
ences in viral sub-types that may lead to longer period
of elevated viral concentration in the early stages of HIV
infection [48] and host genetics and immunology [46]. Our
recent analysis of the risk of HIV transmission within SDCs
in SSA suggests substantial variability across countries [15].
Incorporation of such variability can affect the reported
estimates by increasing the contribution of within-couple
transmission, wherever the risk of HIV transmission is higher,
and reducing the within couple HIV transmission, wherever
the risk of HIV transmission is lower. Similarly, if the country-
specific HIV population incidence rates were actually lower
than those estimated by the SPECTRUM model or derived
using the DHS HIV prevalence, this would increase the con-
tribution of within couple HIV transmission at the expense of
other contributions.
We also parameterized our model using p during acute
infection as derived by Pinkerton using the Rakai cohort data
[22,25]. This value is similar to those reported by Hollings-
worth et al. [49], Powers et al. [50] and Boily et al. [51]. Given
the small contribution of SCNCextint (Figures 2 and 3C), it is
not likely that the uncertainty in p during acute infection [52]
will affect our findings.
In the absence of country-specific empirical measures, we
assumed that the risk of HIV acquisition among individuals
not in SCs is equal to the HIV population-level incidence rate.
This assumption is reasonable on balance of our knowledge
of HIV epidemiology among persons in SCs and not in SCs,
and the fact that individuals not in SCs constitute a large
fraction of the population in reproductive age, nearly half of
it, across countries. Empirical data, such as those of the Rakai
Study [33], as well as HIV incidence age-distribution patterns
in SSA that are skewed towards young age [53], support also
the plausibility of this assumption.
We structured our model to derive the probability of
acquiring HIV from sources external to the couple (l) and
hence, increase the precision of our contribution measures.
Our estimates for the average l as calculated using 10,000
runs of model fits were reasonable in terms of their scale,
since, as expected, they were close yet smaller than the HIV
population-level incidence rate estimated through SPECTRUM
or derived from DHS.
The structure of our model does not consider variations in
partnership duration among SCs. However, the long durations
of stable partnerships [15], and the large rates of engagement
in SCs across SSA (Table 1), suggest that partnership forma-
tion and dissolution within the course of a year of observa-
tion would not be substantial enough to affect our findings.
Finally, we have relied on a volume of data sources derived
using different methodologies to draw a comprehensive
assessment for the contribution of SCs to the HIV epidemic
across the African continent. This may have potentially led to
inconsistencies that could impact our predictions. Though the
above mentioned limitations may have affected the precision
of our quantitative results, our uncertainty analyses suggest
that they are not likely to affect our findings that no single
mode of exposure among SCs contributes the majority of HIV
incidence that is occurring in SSA.
In conclusion, we presented a comprehensive mapping
of the contribution of SCs to HIV incidence in SSA. Our
estimates were based on a mathematical model para-
meterized by state-of-the-art empirical and nationally-
representative population-based data. We conclude that no
single mode of exposure among SCs contributes to the
majority of HIV incidence. Accordingly, a multi-focus HIV
prevention strategy that optimizes the use of available
prevention interventions by targeting the different modes
of exposure to HIV in the population, each according to
its contribution weight, is needed to address the HIV
epidemic in SSA. Further translational research and inter-
vention impact assessments are needed to delineate more
specific recommendations for HIV policy and programming.
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